Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Clinical Kidney Journal|April 8, 2026
A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathyTrisha D Laxamana, Fernando C Fervenza, Richard J Glassock, et al.
Clinical Kidney Journal|April 13, 2018
Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adultsNicola Lepori, Ladan Zand, Sanjeev Sethi, et al.
Kidney360|October 25, 2024
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?Fernando Caravaca-Fontán, Federico Yandian, Ladan Zand, et al.
Kidney360|February 13, 2026
Clinicopathologic Features and Prognostic Factors in Biopsy-Confirmed Renal Involvement in Primary Sjőgren's SyndromeCharat Thongprayoon, Wisit Cheungpasitporn, Alessia Buglioni, et al.
Clinical Kidney Journal|December 16, 2014
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlationsSanjeev Sethi, Ladan Zand, Samih H Nasr, et al.
In Vitro Cellular & Developmental Biology. Animal|September 25, 2003
Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasionLadan Zand, Feng Qiang, Calvin D Roskelley, et al.
American Journal of Hypertension|December 21, 2005
Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?Azra Mahmud, Mohammed Mahgoub, Mary Hall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
What are we missing in the clinical trials of focal segmental glomerulosclerosis?Ladan Zand, Richard J Glassock, An S De Vriese, et al.
Pageof 10